Class II · ModerateRecall completed
Metoprolol Succinate
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLots# 21141983, 21141984 and 21141985, Exp 03/31/2023; Lots# 21142017, 21142018, 21142019, Exp 02/28/2023
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Dissolution Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byAlkem Laboratories Ltd., Mumbai - 400 013 INDIA foreign manufacturer
| Brand name | METOPROLOL SUCCINATE |
| Generic name | METOPROLOL SUCCINATE ER TABLETS |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Distributed by / for | American Health Packaging |
| NDC | 68001-501-03 |
Show the full FDA record
| Full product label | Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03 |
| Recalling firm | American Health Packaging |
| Distribution | Nationwide in the USA |
| Quantity | 6,637 500-count bottles |
| Recall initiated | 2021-12-20 |
| Report date | 2022-02-02 |
| Recall completed | 2023-03-09 |
| Recall number | D-0451-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Columbus OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.